These Analysts Slash Their Forecasts On Universal Health Services Following Q2 Earnings
Universal Health Services Inc (NYSE: UHS ) reported upbeat second-quarter financial results and cut its FY26 adjusted EPS guidance, after the closing bell on Monday. Universal Health reported quarterly earnings of $5.98 per share which beat the analyst consensus estimate of $5.96 per share. The company reported quarterly sales of $4.638 billion which beat the analyst consensus estimate of $4.577 billion. Universal Health Services lowered its FY2026 adjusted EPS guidance from $22.64-$24.52 to $22.28-$23.65. Universal Health shares gained 0.6% to trade at $167.14 on Wednesday. These analysts made changes to their price targets on Universal Health following earnings announcement. Baird analyst Michael Ha maintained the stock with a Neutral and lowered the price target from $204 to $166. Guggenheim analyst Jason Cassorla maintained the stock with a Buy and lowered the price target from $1...
Universal Health Services Inc (NYSE: UHS ) reported upbeat second-quarter financial results and cut its FY26 adjusted EPS guidance, after the closing bell on Monday.
Universal Health reported quarterly earnings of $5.98 per share which beat the analyst consensus estimate of $5.96 per share.
The company reported quarterly sales of $4.638 billion which beat the analyst consensus estimate of $4.577 billion.
Universal Health Services lowered its FY2026 adjusted EPS guidance from $22.64-$24.52 to $22.28-$23.65.
Universal Health shares gained 0.6% to trade at $167.14 on Wednesday.
These analysts made changes to their price targets on Universal Health following earnings announcement.
Baird analyst Michael Ha maintained the stock with a Neutral and lowered the price target from $204 to $166.
Guggenheim analyst Jason Cassorla maintained the stock with a Buy and lowered the price target from $195 to $189.
Considering buying UHS stock? Here’s what analysts think: Photo via Shutterstock